tiprankstipranks
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
US Market

Ginkgo Bioworks Holdings Financial Overview

Ginkgo Bioworks Holdings's market cap is currently ―. The company's EPS TTM is $-12.903; its P/E ratio is ―; Ginkgo Bioworks Holdings is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-1.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue
Gross Profit$ 197.45M$ 294.14M$ 204.16M$ 61.05M
Operating Income$ -864.41M$ -2.21B$ -1.83B$ -137.03M
EBITDA$ -792.98M$ -2.05B$ -1.81B$ -108.58M
Net Income$ -892.87M$ -2.10B$ -1.83B$ -126.61M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―
Total Assets$ 1.67B$ 2.54B$ 2.07B$ 675.15M
Total Debt$ 221.84M$ 413.26M$ 22.28M$ 17.00M
Net Debt$ -722.24M$ -902.54M$ -1.53B$ -363.80M
Total Liabilities$ 568.19M$ 803.04M$ 503.61M$ 205.10M
Stockholders' Equity$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -331.87M$ -304.47M$ -310.34M$ -193.65M
Operating Cash Flow$ -295.50M$ -252.20M$ -253.82M$ -135.83M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

Ginkgo Bioworks Holdings Debt to Assets

Ginkgo Bioworks Holdings Cash Flow

Ginkgo Bioworks Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis